Skip to main content
China Legal Guides · Source station

Life Sciences and Healthcare in China: Key Laws and Primary Sources

A maintained source spine for legal and compliance teams working across China product regulation, clinical research, health data, anti-corruption, procurement, intellectual property and cross-border regulatory interfaces.

Source guide

Maintained source orientation · Qualified PRC counsel required for fact-specific decisions

Research principle

Use this page as a source spine, not as a substitute for full regulatory research.

Open the current official text, confirm its effective version and pair it with the specialist guide that operationalises the issue. English summaries on the portal are orientation only.

Source map

Six research collections organise the sector.

Each collection connects official authorities to the operational guide that owns the practical question.

01

Product registration, advertising and vigilance

NMPA registration, marketing-authorisation-holder duties, advertising, vigilance, product quality and recall.

Product track
02

Clinical research and human genetic resources

Clinical-trial management, GCP, ethics, subject protection, HGR and data-integrity rules.

Research track
03

Data, privacy and digital health

PIPL, Data Security Law, Cybersecurity Law and health-data transfer mechanisms.

Data track
04

Anti-corruption and procurement

Commercial bribery, criminal overlays, volume-based procurement and distribution practice.

Conduct track
05

IP, patent linkage and deals

Patent linkage, trade secrets, licensing, royalties, tax and foreign-exchange interfaces.

IP track
06

Foreign-regulator interfaces

FDA, EU MDR and IVDR, and investment-screening issues touching China assets or data.

Outbound track

Official authority station

Use current official materials; verify effective dates and implementing rules.

Operational library

Pair sources with the guide that owns the issue.

Open the relevant operational route after locating the controlling materials.

Research escalation

Escalate when a source must be applied to live facts.

A bibliography cannot resolve classification, licensing, data, enforcement or transaction questions on its own.

A deadline or authority action is liveA filing, inspection, recall, investigation or response date requires current advice.

Several regimes overlapProduct, clinical, data, HGR, employment or foreign-regulator rules interact.

An English summary is insufficientThe current official text, local implementation and facts must be reconciled.

Educational information only — not legal advice. Laws, procedures and regulatory practice can change; no lawyer-client relationship is created through use of this page.